NxStage Medical, Inc.  

(Public, NASDAQ:NXTM)   Watch this stock  
Find more results for NXTM
18.20
-0.10 (-0.55%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 17.83 - 18.22
52 week 10.69 - 19.19
Open 18.15
Vol / Avg. 249,991.00/458,592.00
Mkt cap 1.14B
P/E     -
Div/yield     -
EPS -0.39
Shares 62.71M
Beta 0.42
Inst. own 95%
May 6, 2015
Q1 2015 NxStage Medical Inc Earnings Release - 9:30AM EDT - Add to calendar
May 6, 2015
Q1 2015 NxStage Medical Inc Earnings Call - 9:00AM EDT - Add to calendar
Mar 11, 2015
NxStage Medical Inc at Barclays Healthcare Conference - Webcast
Feb 26, 2015
Q4 2014 NxStage Medical Inc Earnings Release
Feb 26, 2015
Q4 2014 NxStage Medical Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -6.22% -8.06%
Operating margin -5.60% -7.36%
EBITD margin - 1.83%
Return on average assets -6.45% -7.89%
Return on average equity -10.34% -12.45%
Employees 3,400 -
CDP Score - -

Address

350 Merrimack St
LAWRENCE, MA 01843-1748
United States - Map
+1-978-6874700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

NxStage Medical, Inc. (NxStage)is a medical device company that develops, manufactures and markets products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. The Company�s primary product is the NxStage System One (System One). It also sells needles and blood tubing sets primarily to dialysis clinics for the treatment of end-stage renal disease (ESRD). The Company operates in two segments: System One and In-Center. It distributes its products in three markets: home, critical care and in-center. In the System One segment it sells and rents the System One, PureFlow SL equipment and disposable products in the home and critical care markets. In the In-Center segment, it sells of blood tubing sets and needles for hemodialysis at dialysis centers and needles for apheresis. The Company�s products include the NxStage System One, Streamline Blood Tubing Sets and AV Fistula and Apheresis Needles.

Officers and directors

Joseph E. Turk Jr. President
Age: 47
Bio & Compensation  - Reuters
Jeffrey H. Burbank Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Matthew W. Towse CPA Chief Financial Officer, Senior Vice President
Age: 52
Bio & Compensation  - Reuters
Robert S. Brown CPA President of NxStage Kidney Care
Age: 56
Bio & Compensation  - Reuters
Winifred L. Swan J.D. Senior Vice President, General Counsel, Secretary
Age: 50
Bio & Compensation  - Reuters
Todd M. Snell Senior Vice President - Quality Assurance, Regulatory & Clinical Affairs
Age: 42
Bio & Compensation  - Reuters
Robert G. Funari Non-Executive Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Jean K. Mixer Director
Age: 47
Bio & Compensation  - Reuters
Daniel A. Giannini CPA Independent Director
Age: 64
Bio & Compensation  - Reuters
Earl R. Lewis Independent Director
Age: 71
Bio & Compensation  - Reuters